During the past decade, St. Vincenz Krankenhaus GmbH conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 9 clinical trials were completed, i.e. on average, 52.9% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 6 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Vincenz Krankenhaus GmbH" #1 sponsor was "Biotronik SE & Co. KG" with 4 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored, "Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company" with 2 trials sponsored and "Daiichi Sankyo, Inc." with 2 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 19 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Vincenz Krankenhaus GmbH" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "St. Vincenz Krankenhaus GmbH" are "Atrial Fibrillation" (6 trials), "Breast Cancer" (3 trials), "Ovarian Cancer" (3 trials), "Heart Failure" (2 trials) and "Hypercholesterolemia" (2 trials). Many other conditions were trialed in "St. Vincenz Krankenhaus GmbH" in a lesser frequency.

Most popular intervention types in "St. Vincenz Krankenhaus GmbH" are "Drug" (16 trials), "Other" (5 trials), "Biological" (4 trials), "Device" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Edoxaban" (2 trials), "5-FU" (1 trials), "5-FU and oxaliplatin" (1 trials) and "Abagovomab" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Vincenz Krankenhaus GmbH" are 26 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "St. Vincenz Krankenhaus GmbH". undefined are not yet recruiting, 7 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in St. Vincenz Krankenhaus GmbH, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in St. Vincenz Krankenhaus GmbH, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".